24/7 Wall StreetTue, 19 May 2026 16:15:16 GMTCiti Initiates BridgeBio at Neutral: Why the Cardiomyopathy Story Isn't a Slam DunkBBIO+0.79%
MarketBeatWed, 13 May 2026 05:04:58 GMTBridgeBio Pharma Touts Attruby Blockbuster Path, 3 Potential Pipeline LaunchesBBIO+0.79%
Seeking AlphaWed, 13 May 2026 04:20:43 GMTBridgeBio Pharma, Inc. (BBIO) Presents at Bank of America Global Healthcare Conference 2026 TranscriptBBIO+0.79%
Seeking AlphaFri, 08 May 2026 15:31:17 GMTBridgeBio Pharma, Inc. (BBIO) Q1 2026 Earnings Call TranscriptBBIO+0.79%
Zacks Investment ResearchThu, 07 May 2026 22:26:10 GMTBridgeBio Pharma (BBIO) Reports Q1 Loss, Tops Revenue EstimatesBBIO+0.79%
Seeking AlphaWed, 29 Apr 2026 21:58:45 GMTBridgeBio: Attruby's Early Dominance Makes The Bull Case Hard To IgnoreBBIO+0.79%
Zacks Investment ResearchWed, 29 Apr 2026 15:01:44 GMTAmphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy?BBIO+0.79%
Zacks Investment ResearchTue, 28 Apr 2026 15:09:20 GMTWill BridgeBio Pharma (BBIO) Report Negative Q1 Earnings? What You Should KnowBBIO+0.79%
Seeking AlphaThu, 23 Apr 2026 15:50:30 GMTBridgeBio Pharma: Genetic Disease Specialist Is Thriving - I'm Upgrading To BuyBBIO+0.79%
